{"name": "Gradalis",
 "permalink": "gradalis",
 "crunchbase_url": "http://www.crunchbase.com/company/gradalis",
 "homepage_url": "http://www.gradalisinc.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "214-442-8100",
 "description": "",
 "created_at": "Fri Jan 04 03:13:29 UTC 2013",
 "updated_at": "Fri Jan 04 03:30:58 UTC 2013",
 "overview": "\u003Cp\u003EGradalis is a privately-held, fully-integrated biotechnology company based in Dallas, Texas that is focused on developing, manufacturing and commercializing drugs, vaccines, tools and diagnostics primarily in the area of cancer. The company has two primary platforms:  one focused on personalized autologous vaccines and the other focused on bifunctional short hairpin RNA delivered via a proprietary lipoplex. Gradalis has its own state of the art GMP manufacturing facility along with high-skilled technical leadership and staff.  \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       31],
      "assets/images/resized/0022/7984/227984v1-max-150x150.jpg"],
     [[250,
       52],
      "assets/images/resized/0022/7984/227984v1-max-250x250.jpg"],
     [[335,
       70],
      "assets/images/resized/0022/7984/227984v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$24M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.prnewswire.com/news-releases/gradalis-inc-closes-24-million-in-series-b-financing-to-advance-late-stage-trials-of-fang-personalized-cancer-vaccine-185525702.html",
    "source_description": "Gradalis, Inc. Closes $24 Million in Series B Financing to Advance Late-Stage Trials of FANG\u2122 Personalized Cancer Vaccine",
    "raised_amount": 24000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 1,
    "funded_day": 3,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2545 Golden Bear Drive",
    "address2": "Suite 110",
    "zip_code": "75006",
    "city": "Carrollton",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": 32.9852206,
    "longitude": -96.8491261}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        122],
       "assets/images/resized/0022/7985/227985v1-max-150x150.jpg"],
      [[250,
        203],
       "assets/images/resized/0022/7985/227985v1-max-250x250.jpg"],
      [[450,
        366],
       "assets/images/resized/0022/7985/227985v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}